Evaluation of Healthcare Workers Safety During Pressurized Intraperitoneal Aerosol Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

July 4, 2018

Study Completion Date

July 4, 2018

Conditions
SafetyHealthy Volunteers
Interventions
OTHER

Blood sample

"Exposed group:~* 15 to 30 minutes before the start of the procedure: 1 EDTA tube of 6 ml for blood (T0)~* 2hours after the end of the procedure: 1 EDTA tube of 6 ml (T1)~Non-exposed group:~\- During the morning (8 to 10 a.m): 1 EDTA tube of 6 ml (T0)"

OTHER

Urinary sample

"Exposed group:~* 15 to 30 min before the PIPAC procedure (T0)~* 2hours after the end of the procedure (T1)~* The next morning after the procedure (T2)~Non-exposed group:~\- During the morning (8 to 10 a.m) (T0)"

Trial Locations (1)

34298

ICM - Val d'Aurelle, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT04014426 - Evaluation of Healthcare Workers Safety During Pressurized Intraperitoneal Aerosol Chemotherapy | Biotech Hunter | Biotech Hunter